OWC Pharmaceutical Research Corp (OWCP)

[Triple9]

That 60% success rate sounds outstanding in the first test on mice (my bold/italics):

Our Research Advancing the Use of Cannabinoid-based Formulations for Multiple Myeloma

In March, 2016 OWCP announced the completion of in-vitro testing of a cannabinoid-based formulation for multiple myeloma. It also announced that the company was beginning preclinical test for efficacy and safety studies in mice.

Multiple myeloma is a cancer of plasma cells in bone marrow, and accounts for approximately two percent of all cancer deaths but is highly fatal, with median survival rate of only 3 years.

The results of our in-vitro testing indicated that specific formulations of the cannabinoids CBD and THC decreased the survival of multiple myeloma cells in a concentration-dependent manner, and resulted in a 100 percent malignant cell death in 60 percent of the infected mice.

With the success of its in-vitro mice study, OWCP has determined to proceed with a pre-clinical, Institutional Review Board approved protocol on mice to duplicate those results. It is hopeful that these further studies will provide the scientific justification for OWCP to proceed with human trials.

This is my very first long-term biotech investment so I don't know much about clinical trials, but 100% effectiveness in 60% of the test population sounds remarkable. Go $OWCP! Go Longs!

Bless the Mods of this Board for sharing their DD! This is a once-in-a-lifetime stock!

https://www.otcmarkets.com/stock/OWCP/news/OWC-Pharmaceutical-Research-Corp-Issues-Annual-Letter-to-Shareholders?id=148669&b=y